Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients
Helmy Selman, Leonardo Rinaldi One Day Medical Center–IVF Unit, Roma, Italy Purpose: To evaluate the efficiency and efficacy of corifollitropin alfa (follicle-stimulating hormone–carboxy terminal peptide) in the treatment of poor responder patients. Methods: A total of 85 poor re...
Saved in:
Main Authors: | Selman H (Author), Rinaldi L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corifollitropin alfa for poor responders patients, a prospective randomized study
by: F. M. Fusi, et al.
Published: (2020) -
The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
by: Seyhan A, et al.
Published: (2011) -
Corifollitropin alfa application in art programs in women over 40 years
by: D A Kuleshova, et al.
Published: (2016) -
Clinical-economic rational of using of prolonged gonadotropin in IVF programs in according to the new opportunities of corifollitropin alfa
by: T A Nazarenko
Published: (2017) -
Individualized controlled ovarian stimulation in expected poor-responders: an update
by: Thor Haahr, et al.
Published: (2018)